Biotech Financing: Divide And Reset

Biotech Financing: Divide And Reset

Nature’s article on biotech’s shifting landscape cites DealForma data showing 2025 venture financing nearing $27B, with more money going to fewer, well-funded startups. Read it here

DealForma Research

Explore More
Neurology R&D Partnerships, M&A and Venture Funding by Tech - Q1 2025 Review

Neurology R&D Partnerships, M&A and Venture Funding by Tech – Q1 2025 Review

Neurology R&D Partnerships, M&A and Venture Funding

Neurology R&D Partnerships, M&A and Venture Funding – Q1 2025 Review

Cancer R&D Partnerships, M&A and Venture Funding by Tech - Q1 2025 Review

Cancer R&D Partnerships, M&A and Venture Funding by Tech – Q1 2025 Review

All of this by stage, disease indication, modality, target…

Schedule your Demo
+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures
DealForma Logo

DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.

Linkedin

Database

Company

Comparisons

Website Design by Once Interactive